Fig. 2: Overall survival analysis in MYC-R patients. | Blood Cancer Journal

Fig. 2: Overall survival analysis in MYC-R patients.

From: A non-randomized risk-adjusted comparison of lenalidomide + R-CHOP versus R-CHOP for MYC-rearranged DLBCL patients

Fig. 2

Overall survival analysis in MYC-R patients treated with R2CHOP in blue versus R-CHOP in red in A an unadjusted comparison of the overall survival by treatment, B comparison of the overall survival in the patients one-to-one matched on IPI risk score, and C doubly robust analysis using AIPTW with IPCW estimate of overall survival. Error bars represent 95% confidence interval.

Back to article page